Free Trial

Tempest Therapeutics (TPST) Insider Trading & Ownership

Tempest Therapeutics logo
$0.90 +0.03 (+3.45%)
(As of 11/20/2024 ET)

Tempest Therapeutics (NASDAQ:TPST) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$100,001.36
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$966,798.90
Get TPST Insider Trade Alerts

Want to know when executives and insiders are buying or selling Tempest Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

TPST Insider Buying and Selling by Quarter

Tempest Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/12/2024Versant Venture Capital Vi, L.Major ShareholderSell387,999$1.10$426,798.90  
8/8/2024Versant Venture Capital Vi, L.Major ShareholderSell400,000$1.35$540,000.00  
7/3/2024Stephen R BradyCEOBuy35,000$2.11$73,850.00  
7/2/2024Samuel WhitingInsiderBuy4,672$2.13$9,951.36  
6/28/2024Justin TrojanowskiInsiderBuy7,500$2.16$16,200.00  
(Data available from 1/1/2013 forward)

TPST Insider Trading Activity - Frequently Asked Questions

The list of insiders at Tempest Therapeutics includes Justin Trojanowski, Samuel Whiting, Stephen R Brady, Thomas W Dubensky, Thomas Woiwode, and Versant Venture Capital Vi, L.. Learn more on insiders at TPST.

4.70% of Tempest Therapeutics stock is owned by insiders. Learn more on TPST's insider holdings.

The following insiders have purchased TPST shares in the last 24 months: Justin Trojanowski ($16,200.00), Samuel Whiting ($9,951.36), and Stephen R Brady ($73,850.00).

Insiders have purchased a total of 47,172 TPST shares in the last 24 months for a total of $100,001.36 bought.

The following insider sold TPST shares in the last 24 months: Versant Venture Capital Vi, L. ($966,798.90).

Insiders have sold a total of 787,999 Tempest Therapeutics shares in the last 24 months for a total of $966,798.90 sold.

Tempest Therapeutics Key Executives

  • Mr. Stephen R. Brady J.D. (Age 54)
    LLM, CEO, President & Director
    Compensation: $923.24k
    1 recent trades
  • Mr. Nicholas Maestas (Age 43)
    VP of Strategy & Finance and Secretary
    Compensation: $465.43k
  • Dr. Samuel Whiting M.D. (Age 58)
    Ph.D., Executive VP & Chief Medical Officer
    Compensation: $667.65k
  • Mr. Justin Trojanowski (Age 36)
    Corporate Controller, Treasurer & Principal Accounting Officer
    1 recent trades
  • Ms. Lindsay Young
    Head of Human Resources
  • Dr. Sharon Sakai Ph.D.
    RAC, Head of Regulatory & Quality


This page (NASDAQ:TPST) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners